Fisher & Paykel Healthcare Corporation Limited Share Price
Equities
FPH
NZFAPE0001S2
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37.44 NZD | -1.47% |
|
-1.32% | -2.50% |
| 12-12 | NZX Midday Sector Update: Consumer Durables Soar, Health Technology Struggles | MT |
| 12-05 | NZX Biggest Losers | MT |
| Capitalization | 21.99B 12.74B 10.85B 10.14B 9.54B 17.56B 1,154B 19.19B 118B 45.9B 544B 47.8B 46.8B 1,985B | P/E ratio 2026 * |
48.8x | P/E ratio 2027 * | 41.8x |
|---|---|---|---|---|---|
| Enterprise value | 21.74B 12.6B 10.73B 10.02B 9.43B 17.36B 1,141B 18.97B 117B 45.38B 538B 47.26B 46.27B 1,962B | EV / Sales 2026 * |
9.63x | EV / Sales 2027 * | 8.59x |
| Free-Float |
91.76% | Yield 2026 * |
1.27% | Yield 2027 * | 1.55% |
Last Transcript: Fisher & Paykel Healthcare Corporation Limited
| 1 day | -1.47% | ||
| 1 week | -1.32% | ||
| Current month | +0.38% | ||
| 1 month | -2.22% | ||
| 3 months | -1.47% | ||
| 6 months | +1.60% | ||
| Current year | -2.50% |
| 1 week | 37.38 |  | 38.52 |
| 1 month | 36.21 | | 40.46 |
| Current year | 31.8 | | 40.46 |
| 1 year | 31.8 | | 40.46 |
| 3 years | 20.29 | | 40.46 |
| 5 years | 18.02 | | 40.46 |
| 10 years | 8.13 | | 40.46 |
| Manager | Title | Age | Since |
|---|---|---|---|
Lewis Gradon
CEO | Chief Executive Officer | 64 | 31/03/2016 |
Lyndal York
DFI | Director of Finance/CFO | - | 22/10/2018 |
Andy Niccol
COO | Chief Operating Officer | - | 31/03/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Daniell
BRD | Director/Board Member | 67 | 31/10/2001 |
Lewis Gradon
BRD | Director/Board Member | 64 | 31/03/2016 |
| Director/Board Member | - | 31/05/2017 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 0.39% | 26 M€ | +12.27% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.47% | -1.32% | +2.30% | +66.55% | 12.74B | |
| +1.77% | +0.30% | +10.19% | +14.59% | 218B | |
| +0.12% | -1.47% | +20.72% | +25.29% | 128B | |
| +0.44% | +1.87% | +49.06% | +106.94% | 67.12B | |
| +0.23% | +3.57% | -11.57% | -20.93% | 57.34B | |
| +1.79% | -0.02% | +16.59% | +73.21% | 51.91B | |
| -2.87% | +2.24% | -15.17% | -42.66% | 26.12B | |
| -0.28% | -4.36% | +16.35% | +29.27% | 24.71B | |
| -1.06% | -3.80% | +5.39% | -35.53% | 23.44B | |
| +0.63% | -2.38% | -25.57% | +15.71% | 21.9B | |
| Average | -0.47% | -0.60% | +6.83% | +23.24% | 63.15B | |
| Weighted average by Cap. | -0.69% | -0.01% | +12.62% | +25.60% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.26B 1.31B 1.11B 1.04B 980M 1.8B 119B 1.97B 12.15B 4.71B 55.87B 4.91B 4.81B 204B | 2.52B 1.46B 1.24B 1.16B 1.09B 2.01B 132B 2.2B 13.55B 5.26B 62.29B 5.47B 5.36B 227B |
| Net income | 452M 262M 223M 208M 196M 361M 23.73B 394M 2.43B 944M 11.18B 983M 962M 40.81B | 527M 305M 260M 243M 229M 421M 27.66B 460M 2.84B 1.1B 13.04B 1.15B 1.12B 47.58B |
| Net Debt | -248M -144M -122M -114M -108M -198M -13.02B -217M -1.34B -518M -6.14B -539M -528M -22.4B | -367M -213M -181M -169M -159M -293M -19.27B -320M -1.98B -766M -9.08B -798M -781M -33.13B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/12/25 | 37.44 $ | -1.47% | 300,469 |
| 11/12/25 | 38.00 $ | +0.29% | 441,621 |
| 10/12/25 | 37.89 $ | -0.45% | 557,187 |
| 09/12/25 | 38.06 $ | -0.34% | 676,386 |
| 08/12/25 | 38.19 $ | +0.66% | 259,991 |
End-of-day quote New Zealand S.E., December 11, 2025
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- FPH Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition